Effect of tofacitinib on pain, fatigue, health-related quality of life and work productivity in patients with active ankylosing spondylitis: results from a phase III, randomised, double-blind, placebo-controlled trial

Lignende værker

• Integrated safety analysis of tofacitinib from Phase 2 and 3 trials of patients with ankylosing spondylitis
  af: Atul Deodhar, et al.
  Udgivet: (2024-12-01)
• Comparative efficacy of tofacitinib and biologics in ankylosing spondylitis
  af: CHEN Jianming, et al.
  Udgivet: (2026-06-01)
• Improvement of Fatigue in Patients with Ankylosing Spondylitis Receiving Tofacitinib: Analyses of a Phase 3 Randomized Controlled Trial
  af: Laure Gossec, et al.
  Udgivet: (2024-12-01)
• Ankylosing Spondylitis
  af: Nazanin Ebrahimiadib, et al.
  Udgivet: (2021-07-01)
• EXPERIENCE WITH RITUXIMAB IN PATIENTS WITH ANKYLOSING SPONDYLITIS
  af: Mikhail Sergeyevich Protopopov, et al.
  Udgivet: (2013-02-01)